About
What is VICH
Role of VICH
VICH Structure
VICH Process
What is the VICH Outreach Forum
Guidelines
General
Biologicals
Pharmaceuticals
Pharmacovigilance
Activities
Dates of next meetings
Dates of next Public conference
Public consultations
Library
Press releases
VICH Statements
VICH Steering Committee Minutes
VICH Outreach Forum minutes
Concept Papers
Procedural Guidance
Organisational documents (Priorities, Strategy and charter)
Conference documents archive
Other Documents
Training
General training material
Module 1 - General Topics
Module 2 - Quality
Module 3 - Efficacy
Module 4 - Safety
Module 5 - Biologicals
Module 6 - Pharmacovigilance
Contact
Members login
Remember me next time
I agree to the
privacy policy
Guidelines
Quality
Impurities
Stability
Specifications
Safety
Batch safety testing
Target animal safety
Efficacy
Target animal batch safety
Harmonisation of criteria to waive target animal batch safety testing for inactivated vaccines for veterinary use (Revision at Step 9)
VICH GL50 (R) (Biologicals - TABST inactivated vaccines) - May 2017 - for implementation in the regions at Step 7 by May 2018
Harmonisation of criteria to waive target animal batch safety testing for live vaccines for veterinary use
VICH GL55 (Biologicals - TABST live vaccines) - May 2017 - for implementation in the regions at Step 7 by May 2018
Harmonisation of criteria to waive Laboratory Animal Batch Safety Testing for vaccines for veterinary use
VICH GL 59 (Biologicals: LABST veterinary vaccines) - November 2020 - for implementation in the regions at Step 7 by November 2021